In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...

Viking Therapeutics (VKTX) released new clinical trial data on Sunday for its experimental weight-loss drugs, which include a ...

Viking Therapeutics Inc.’s stock was up up as much as 3.8% early Friday as excitement continued to build about data on the ...

AstraZeneca and Viking Therapeutics both presented encouraging data on their obesity pills. Meanwhile, here’s how Americans ...

New research shows that weight loss medications can stop the progression of prediabetes. Experts don’t all agree on such a ...

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, ...

Losing more than 8% of weight in less than a month. This is the promise of a pill under experimentation in the laboratories ...

Amid growing concerns over counterfeit weight loss medications, a local clinical trial may offer a safer alternative for ...

Viking Therapeutics shares surge as VK2735 shows significant weight loss in early-stage study, with plans for a phase 2 study ...

Many companies, including market leaders Novo Nordisk (DK:NOVO.B) (NVO) and Eli Lilly & Co. (LLY), are working to develop a weight-loss pill. Jefferies is confident Viking's stock still has plenty ...